Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Kidney Neoplasms × Alemtuzumab × Clear all

Sponsor

Conditions

Leukemia 27 Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma 16 Myelodysplastic Syndromes 11 Hodgkin Disease 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Leukemia, Myeloid, Acute 7 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Recurrence 5 Myeloproliferative Disorders 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Chronic-Phase 5 Hematologic Neoplasms 5 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, B-Cell, Marginal Zone 4 Anemia, Aplastic 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Large Granular Lymphocytic 3 Immunoblastic Lymphadenopathy 3 Hematologic Diseases 3

Interventions

Sunitinib 16 Everolimus 15 Bevacizumab 12 aldesleukin 10 Sorafenib 10 Cyclophosphamide 10 Nivolumab 9 Interleukin-2 9 fludarabine phosphate 7 fludarabine 7 Axitinib 7 Gemcitabine 5 temsirolimus 4 pembrolizumab 4 pazopanib 4 Ipilimumab 4 peginterferon alfa-2b 3 durvalumab 3 Radiosurgery 3 Interferon-alpha 3 Filgrastim 3 Erlotinib Hydrochloride 3 Cryosurgery 3 vandetanib 2 perflutren 2 ixabepilone 2 chiron 2 carfilzomib 2 cabozantinib 2 belzutifan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡